Therapeutic approaches for reducing specific lipoproteins (Lp(a)) Lp(a) has been increasingly recognized as a risk factor for cardiovascular disease in recent years, and its potential link to non-cardiovascular diseases, including stroke, peripheral vascular disease, cancer, and diabetes, has also begun to attract attention
Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4
Key Information 
Oral treatment with ALCAR (1.5g twice daily) has shown some beneficial effect on symptoms and nerve regeneration in patients with ATN [15-18]
L., Saad, S., Al-Odat, I., Oliver, B
Histamine flows in from multiple sources: Pollen-triggered mast cell release Stress-triggered mast cell activation Histamine in food (aged cheese, fermented foods, leftover meat) Histamine produced by gut bacteria Other immune triggers (infections, exercise, temperature changes) At the bottom of the bucket, DAO and HNMT act as drains